Stroke is the leading cause of death and disability in Chinese residents, and acute ischemic stroke accounts for about 80% of all stroke types. Its disability and death rate have been high for many years. Therefore, actively exploring its pathogenesis and in-depth study of its effective prevention and treatment methods have become a major medical topic of great scientific significance and social value. Fuyuan Xingnao Decoction is a traditional Chinese medicine compound created under the guidance of the traditional Chinese medicine theory "Fuyuan Xingnao Method". It is clinically used in the treatment of acute ischemic stroke and has significant therapeutic effect, which can improve the protection of blood-brain barrier, anti-atherosclerosis, promote angiogenesis, improve nerve function, anti-coagulation and anti-platelet aggregation. By collating, summarizing and analyzing a large number of relevant literatures, the mechanism of Fuyuan Xingnao Decoction in the treatment of acute ischemic stroke was reviewed, in order to provide scientific theoretical basis for the treatment of ischemic stroke-related diseases with Fuyuan Xingnao Decoction as the starting point.

Liu Jun, Fang Bangjiang. Research Progress on the Mechanism of Fuyuan Xingnao Decoction in the Treatment of Acute Ischemic Stroke. Academic Journal of Medicine & Health Sciences (2023) Vol. 4, Issue 12: 103-109. https://doi.org/10.25236/AJMHS.2023.041214.

[1] "China Stroke Prevention and Treatment Report 2019" compilation group. "China Stroke Prevention and Treatment Report 2019" summary [J]. Chinese Journal of Cerebrovascular Diseases, 2020, 17 (5): 272-281. 

[2] Yu Xihe, Gao Sheng, Jia Huanhuan, et al. Study on the Burden of Stroke in China and the World in 1999, 2009, and 2019 [J]. Chinese Health Economy 2021, 40 (6), 58-61. 

[3] Wang Yongjun, Li Zixiao, Gu Hongqiu, et al. Chinese Stroke Prevention and Treatment Report 2019 (Chinese version) (1) [J]. Chinese Journal of Stroke, 20, 15 (10): 1037-1043. 

[4] Chinese Stroke Prevention and Treatment Report 2019 Compilation Group, Wang Longde. Brief report on stroke prevention and treatment in China, 2019 [J]. Chinese Journal of Cerebrovascular Diseases, 2020, 17 (5), 272-281.

[5] None. Stroke and ischemic heart disease are the major disease burden in China [J]. Cardiovascular disease prevention Knowledge (Science Edition), 2019(19):5. 

[6] Wu Q, Wang C Ran, Zhao Y, et al. Study on the burden and trend of stroke and its subtypes in China [J]. Modern Preventive Medicine, 2019, 48 (12): 2113-2119. 

[7] Shu Y, Zeng L, Qi Xunjie, et al. Observation on hemorrheology of Yiqi Huoxue Huayu decoction in treatment of stroke with Qi deficiency and blood stasis [J]. Journal of Microcirculation, 2012, 22(2):51-52. 

[8] Zhang Bosou. Chinese Medicine Internal Medicine [M]. Shanghai: Shanghai Science and Technology Press, 2006:208-213. 

[9] Hu Jianhua. Hu Jianhua's academic experience [M]. Shanghai: Shanghai University of Traditional Chinese Medicine Press, 2005:1. 

[10] Liu Yue, Fang Bangjiang, Wang Xiaocui, et al. Research progress of AT1R vesicle transport mediated by Rab1 protein in vascular remodeling in diabetic cerebral infarction [J]. Shanghai Pharmaceutical, 2016, 37 (19):45-47. 

[11] Liebner S, Dijkhuizen RM, Reiss Y, et al. Functional morphology of the blood-brain barrier in health and disease[J]. Acta Neuropathol, 2018; 135(3): 311-316. 

[12] Huang Jinyang, Wang Hong, Fang Bangjiang. Effect of Fuyuan Xingnao Decoction on blood-brain barrier in diabetic cerebral infarction rats [J]. Jiangsu Traditional Chinese Medicine, 2013, 45 (8): 68-70. 

[13] Lin Mei, Fang Bangjiang, Zhou Shuang, et al. Experimental study on the effect of Fuyuan Xingnao Decoction on blood-brain barrier permeability in hypertensive cerebral hemorrhage rats [J]. Journal of Gerontology and Health Care, 2010, 16 (2): 112-115. 

[14] Fang Bangjiang, Zhou Shuang, Chen Baojin, et al. Effect of Fuyuan Xingnao Decoction on the permeability of blood-brain barrier in hypertensive cerebral hemorrhage rats [J]. Modern distance Education of Chinese Medicine, 2010, 8 (17): 206-208. 

[15] Lin Mei, Fang Bangjiang, Chen Baojin, et al. Effect of Fuyuan Xingnao Decoction on brain histomorphology of hypertensive cerebral hemorrhage rats [J]. Zhejiang Journal of Integrated Chinese and Western Medicine, 2010, 20 (6): 338-341. 

[16] Fang Bangjiang, Zhou Shuang, Chen Baojin, et al. Experimental study on the effect of Fuyuan Xingnao Decoction on brain histomorphologic changes in rats with hypertensive cerebral hemorrhage [J]. Modern Distance Education of Chinese Medicine, 2010, 8 (18): 182-184. 

[17] Chen Miao, Wang Hong, Fang Bangjiang. Mechanism of Fuyuan Xingnao Decoction in the treatment of diabetes mellitus complicated with cerebral infarction [J]. Chinese Journal of Emergency Medicine, 2013, 33(7): 654-657. 

[18] Fang Bangjiang, Zhou Shuang, Shen Junyi, et al. Effects of Fuyuan Xingnao Decoction on blood flow and water content of cerebral tissue in diabetic cerebral infarction rats [J]. Geriatrics and Health Care, 2012, 18 (6): 381-385.

[19] Deng D, Ye MiAqing, Chen Zhenyi, et al. Research progress of the mechanism of Fuyuan Xingnao Decoction in the treatment of diabetes mellitus complicated with cerebral infarction [J]. Journal of Integrated Traditional Chinese and Western Medicine Cardio-Cerebrovascular Diseases, 2019, 3 (1): 135-138. 17 (18): 2774-2778. 

[20] Zhao X F, Zheng H B, Liu C Y. Research progress of SIRT6 in atherosclerosis [J]. Chinese Journal of Gerontology, 2019, 41(11):2436-2439. 

[21] Libby Peter. The changing landscape of atherosclerosis [J]. Nature, 2021, 592(7855):524-533. 

[22] Yu Feng, Xin Mengxue, Hong Yongdun. Investigation of Traditional Chinese medicine prevention and treatment of atherosclerosis based on the theory of "vacuity-blood-toxicity" [J]. Journal of Modern Chinese and Western Medicine Integration, 2022, 31(19):2720-2723. 

[23] Ma Xiaodong, Qu Changhong, Wang Daocheng, et al. Study on the connotation of Traditional Chinese medicine based on "adverse pulse" in atherosclerotic endothelial injury [J]. Chinese Ethnic and Folk Medicine, 2022, 31(15):5-7.

[24] Fang Lingyun. Effects of Fuyuan Xingnao Decoction on serum ox-LDL, IL-18, Lp-PLA2 levels and carotid atherosclerotic plaque in patients with wind-phlegm-stasis cerebral infarction [J]. Modern Journal of Integrated Chinese and Western Medicine Traditional Chinese and Western Medicine 2019 Jun, 28(17): 1904-1907.

[25] Liang Z, Chi YJ, Lin GQ, et al. MiRNA-26a promotes angiogenesis in a rat model of cerebral infarction via PI3K/AKT and MAPK/ERK pathway [J]. European review for medical and pharmacological sciences, 2018, 22(11):3485-3492. 

[26] Kawabori Masahito, Yenari Midori A. Inflammatory responses in brain ischemia [J]. Current medicinal chemistry, 2015, 22(10):1258-1277. 

[27] Zhang Z G, Zhang L, Jiang Q, et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain [J]. The Journal of clinical investigation, 2000, 106(7): 829-838. 

[28] Hatakeyama M, Ninomiya I, Kanazawa M. Angiogenesis and neuronal remodeling after ischemic stroke. Neural Regen Res. 2020; 15:16-19. 

[29] Meng Xiuyan. Mechanism analysis of Fuyuan Xingnao Decoction in the treatment of experimental diabetes mellitus complicated with cerebral infarction [J]. Inner Mongolia Traditional Chinese Medicine, 2014, 33 (32): 53-54.

[30] Shen Junyi, Fang Bangjiang, Zhao Zhming, et al. Effects of Fuyuan Xingnao Decoction on microRNA-503, CCNE1, CDC25A protein expression in diabetic cerebral infarction rats and experimental study on promoting angiogenesis [J]. Chinese Journal of Acute Chinese Medicine, 2018, 27 (11): 1881-1885, 1890. 

[31] Wang Liping, Liu Cuimei, et al. Effect of Fuyuan Xingnao Decoction combined with Western Medicine on lacunar cerebral infarction and its influence on IL-6, TNF-α and NO Modern [J]. Journal of Integrated Traditional Chinese and Western Medicine, 2015, 24(29)3207-3208+3306.

[32] Xudong Chen, Siyang Lin, Lei Gu, et al. Inhibition of miR-497 improves functional outcome after ischemic stroke by enhancing neuronal autophagy in young and aged rats [J]. Neurochemistry International, 2019, 127:64-72. 

[33] Guo Qiyun, Guo Mujie, Zhang Lin, et al. Correlation analysis between self-efficacy and fall efficacy in stroke patients [J]. Chinese Journal of Behavioral Medicine and Brain Science, 2016, 25 (4): 347-349. 

[34] Sanie Jahromi Fatemeh, Mahmoudi Ahmad, Khalili Mohammad Reza, et al. A Review on the Application of Stem Cell Secretome in the Protection and Regeneration of Retinal Ganglion Cells; a Clinical Prospect in the Treatment of Optic Neuropathies [J]. Current eye research, 2022, 47(11):1-9. 

[35] Chen Zhenyi, Fang Bangjiang, Yan  Zhao, et al. Clinical Study on the Correlation between Thrombus Elasticity and Coagulation Function in Patients with Acute Cerebral Infarction Based on Fuyuan Xingnao Method [J]. Journal of Liaoning University of Traditional Chinese Medicine, 2017, 19(12):69-72. 

[36] Meng Xiuyan. Mechanism analysis of Fuyuan Xingnao Decoction in treating experimental diabetes mellitus complicated with cerebral infarction [J]. Inner Mongolia Traditional Chinese Medicine, 2014, 33 (32): 53-54. 

[37] Huang Jinyang, et al. Effect of Fuyuan Xingnao Decoction on blood-brain barrier in diabetic cerebral infarction rats [J]. Jiangsu Chinese Medicine, 2013, 45 (8): 68-70. 

[38] Geng Yun, Fang Bangjiang, Ma Zhihui. Clinical study of Fuyuan Xingnao Decoction in treatment of acute ischemic stroke [J]. Chinese Journal of Acute Chinese Medicine, 2014, 24 (11): 1970-1972. 

[39] He Shaohua. Study on the mechanism of Fuyuan Xingnao Decoction in treating diabetes mellitus complicated with cerebral infarction [J]. Chinese Journal of Continuing Medical Education, 2015, 7 (3):233-234. 

[40] Shen Junyi, Fang Bangjiang, Ling Li, et al. Effect of Fuyuan Xingnao Decoction on SDF-1, CXCR4, VEGF gene and protein expression in diabetic cerebral infarction rats [J]. Chinese Emergency Medicine, 2016, 25 (8): 1457-1460. 

[41] Wang Aili, Wang Xue, Zhu Taiqing. Clinical study on Fuyuan Xingnao Decoction assisting in the treatment of acute cerebral infarction New Chinese Medicine 2022. 54. (9):67-71.

[42] Shu Xuemei, Guo Tao. Research progress of platelet receptor as target of antiplatelet therapy [J]. Journal of Clinical Hematology, 20, 33(1):13-17. 

[43] Zhang Jiandong, Wu Xiangyun, Ren Huiling, et al. Relationship between antiplatelet drug reactivity and platelet parameters and coagulation function in patients with acute ischemic stroke [J]. Hebei Journal of Medicine, 2019, 45(6):876-878. 

[44] Chen Jimin, Li Liantai, Sun Yanhong. Effect of Fuyuan Xingnao Decoction on Coagulation Indexes and Long-term Prognosis in Convalescent Patients with Cerebral Ischemic Stroke [J]. Medical Recapitulate, 2019, 25(17):3526-3531.

[45] Zhuang Dahe, He Lishan. Effect of Fuyuan Xingnao Decoction combined with conventional Western medicine on patients with acute cerebral infarction (wind-phlegm-stasis syndrome) and its influence on coagulation function [J]. Straits Pharmacology, 2018, 30(11):95-96.

[46] Chen Zhenyi, Fang Bangjiang, Liu Yue. Effect of Fuyuan Xingnao Decoction on coagulation function in patients with acute cerebral infarction (wind-phlegm-stasis syndrome) [J]. Chinese Emergency Medicine, 2017, 26 (8): 1317-1319. 

[47] Sun Lihua, Ye Miaoqing, Shen Junyi, et al. Experimental study on the effect of Fuyuan Xingnao Decoction on the angiogenesis of ischemic brain tissue in diabetic cerebral infarction rats [J]. Chinese Journal of Emergency Medicine, 2019, 28(2):192-195+199. 

[48] Zhao Ping, Shen Junyi, Wei Junping, et al. Effect of Fuyuan Xingnao Decoction on cerebral infarction volume of diabetic rats [J]. Journal of Shanghai University of Traditional Chinese Medicine, 2013, 27 (5):66-69.

[49] Ling Li, Shen Junyi, Chen Miao, et al. Experimental study on the effect of Fuyuan Xingnao Decoction on the volume and morphology of cerebral infarction in diabetic rats [J]. Chinese Emergency Medicine, 2018, 27(2):189-193.